Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: Influence of continuous subcutaneous insulin infusion and lispro insulin

Diabetes Technology and Therapeutics

Volumn 12, Issue 12, 2010, Pages 937-945

  Chico, Ana ^a   Saigi, Ignasi ^a   García Patterson, Apolonia ^a   Santos, M Dolores ^a   Adelantado, Juan M ^a   Ginovart, Gemma ^b   De Leiva, Alberto ^a   Corcoy, Rosa ^a  

^a HOSPITAL SANT PAU   (Spain)

^b Sant Pau University Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; FEMALE; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; HYPOGLYCEMIC COMA; INSULIN DEPENDENT DIABETES MELLITUS; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MAJOR CLINICAL STUDY; NEWBORN MORTALITY; PERINATAL MORTALITY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RISK REDUCTION; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; STILLBIRTH; THIRD TRIMESTER PREGNANCY; WEIGHT GAIN;

ADULT; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; REGRESSION ANALYSIS;

EID: 78650104110     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0111     Document Type: Article

References (32)

1. Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N: Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 2004; 8(43):iii, 1-171.
2. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM: Hypoglycemia with intensive insulin therapy: a systematic review and metaanalyses of randomized trials of continuous subcutaneous insulin infusion vs. multiple daily injections. J Clin Endocrinol Metab 2009;94: 729-740.
3. Chen R, Ben-Harousch A, Weissmann-Brenner A, Melamed N, Hod M, Yogev Y: Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 2007;1997:404.e1-404e5.
4. Diamond T, Kormas N: Possible adverse fetal effect of insulin lispro. N Engl J Med 1997;337:1009.
5. Kitzmiller JL, Main E, Ward B, Theiss T, Peterson DL: Insulin lispro and the development of proliferative diabetic reti-nopathy during pregnancy. Diabetes Care 1999;22:874-876.
6. Evers IM, de Walk HW, Mol BWJ, ter Braak EWMT, Visser GHA: Macrosomia despite glood glycemic control in Type 1 diabetic pregnancy; results of a nationwide study in the Netherlands. Diabetologia 2002;45:1484-1489.
7. Lapolla A, Dalfrà MG, Spezia R, Anichini R, Bonomo R, Bruttomesso D, Di Cianni G, Franzetti I, Galluzzo A, Mello G, Menato G, Napoli A, Noacco G, Parretti E, Santini C, Scaldaferri E, Scaldaferri L, Songini M, Tonutti L, Torlone E, Gentilella R, Rossi A, Valle D: Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol 2008;45:61-66.
8. Harris JA, Benedict FG. A Biometric Study of Basal Metabolism in Man. Publication number 279. Washington, DC: Carnegie Institution of Washington, 1919.
9. Durnin JG: Energy requirements of pregnancy. Diabetes 1991;40(Suppl 2):152-156.
10. Santamaria Lozano R, Verdú Mart́in L, Martín Caballero C, Garćia López G: Tablas españolas de pesos neonatales según edad gestacional. Badalona, Spain: Ed Artes Gráficas Bea-tulo, 1998.
11. Boulot P, Chabbert-Buffet N, d'Ercole C, Floriot M, Fontaine P, Fournier A, Gillet JY, Gin H, Grandperret-Vauthier S, Geudj AM, Guionnet B, Hauguel-de-Mouzon S, Hieronimus S, Hoffet M, Jullien D, Lamotte MF, Lejeune V, Lepercq J, Lorenzi F, Mares P, Miton A, Penfornis A, Pfister B, Renard E, Rodier M, Roth P, Sery GA, Timsit J, Valat AS, Vamber-gue A, Verier-Mine O; Diabetes and Pregnancy Group, France: French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003;26:2990-2993.
12. Penney GC, Mair G, Pearson DW; Scottish Diabetes in Pregnancy Group: Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population-based study. BJOG 2003;110:315-318.
13. Evers IM, de Valk HW, Visser GHA: Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004;328:915-920.
14. Pickup J, Mattock M, Kerry S: Glycemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: metaanalysis of randomised controlled trials. BMJ 2002;324: 705.
15. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R: Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26: 1079-1087.
16. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J: Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010;(1):CD005103.
17. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care 1996;19:324-327.
18. Mukhopadhyay A, Farell T, Fraser RB, Ola B: Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007;197:447-456.
19. Farrar D, Tuffnell DJ, West J: Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007;(3):CD005542.
20. Rudolf MCJ, Coustan DR, Sherwin RS, Bates SE, Felig P, Genel M, Tamborlane WV: Efficacy of the insulin pump in the home treatment of pregnant diabetics. Diabetes 1981;30: 891-895.
21. Pratoomsoot C, Smith HT, Kalsekar A, Boye KS, Arellano J, Valentine WJ: An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK. Diabet Med 2009; 26:803-814.
22. Wyatt JW, Frias JL, Hoyme HE, Jovanovic L, Kaaja R, Brown F, Garg S, Lee-Parritz A, Seely EW, Kerr L, Mattoo V, Tan M; IONS study group: Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med 2005;22:803-807.
23. Durnwald CP, Landon MB: A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonatal Med 2008;21: 309-313.
24. Coustan DR, Reece EA, Sherwin RS, Rudolf MC, Bates SE, Sockin SM, Holford T, Tamborlane WV: A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 1986; 255:631-636.
25. Catargi B, Breilh D, Roger P, Tabarin A: Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump. Diabetes Metab 2000;26:210-214.
26. Ahmed AB, Home PD: Optimal provision of daytime NPH insulin in patients using the insulin analog lispro. Diabetes Care 1998;21:1707-1713.
27. Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S, Bellaire S, Raben A; Insulin Aspart Pregnancy Study Group: Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007;30:771-776.
28. Persson B, Swahn ML, Hjertberg R, Hanson U, Nord E, Nordlander E, Hansson LO: Insulin lispro therapy in pregnancies complicated by type 1 diabetes. Diabetes Res Clin Pract 2002;58:115-121.
29. González-Romero S, González-Molero I, Fernández- Abellán M, Doḿinguez-López ME, Ruiz-de-Adana S, Ol-veira G, Soriguer F: Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes. Diabetes Technol Ther 2010;12:263-269.
30. Hod M, Damm P, Kaaja R, Visser GH, Dunne F, Demidova I, Hansen AS, Mersebach H; Insulin Aspart Pregnancy Study Group: Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008;198:186.e1-186e7.
31. Carta Q, Meriggi E, Trossarelli GF, Catell G, Dal Molin V, Menato G, Gagliardi L, Massobrio M, Vitelli A: Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type 1 and type 2 diabetic pregnancy. Diabet Metab 1986;12:121-129.
32. Gonzalez S, Gonzalo M, Gomez L, Domínguez M, Ruiz de Adana MS, Esteva I, Olveira G, Garćia Arnés J, Soriguer FC, Garćia Alemán J: Tratamiento con insulina lispro en gestantes con diabetes pregestacional. Control metabólico y evolución obstétrica y neonatal comparado con un grupo control [abstract] Endocrinol Nutr 2005;52:A22